Avid Bioservices Inc.

19.36+0.1800+0.94%Vol 491.56K1Y Perf -25.97%
Aug 5th, 2022 16:00 DELAYED
BID14.80 ASK23.00
Open18.80 Previous Close19.18
Pre-Market- After-Market19.36
 - -  - -%
Target Price
28.33 
Analyst Rating
Moderate Buy 2.00
Potential %
46.33 
Finscreener Ranking
★★★★+     56.33
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     56.23
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     70.31
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
34.73 
Earnings Rating
Neutral
Market Cap1.20B 
Earnings Date
14th Sep 2022
Alpha0.02 Standard Deviation0.21
Beta2.11 

Today's Price Range

18.8019.52

52W Range

11.3034.51

5 Year PE Ratio Range

-18.80862.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-1.48%
1 Month
15.86%
3 Months
53.29%
6 Months
-0.05%
1 Year
-25.97%
3 Years
206.81%
5 Years
396.41%
10 Years
58.04%

TickerPriceChg.Chg.%
CDMO19.360.18000.94
AAPL165.35-0.2300-0.14
GOOG118.22-0.6500-0.55
MSFT282.91-0.7400-0.26
XOM88.451.26001.45
WFC43.760.99002.31
JNJ171.11-0.6800-0.40
FB196.640.99000.51
GE74.360.69000.94
JPM115.763.40003.03
 
ProfitabilityValueIndustryS&P 500US Markets
30.60
15.00
18.40
-8.50
13.66
RevenueValueIndustryS&P 500US Markets
119.60M
1.93
29.61
10.78
Earnings HistoryEstimateReportedSurprise %
Q04 2022-0.020.04300.00
Q03 20220.050.0620.00
Q02 2022-0.010.07800.00
Q01 20220.020.10400.00
Q04 20210.00-0.04-
Q03 2021-0.020.01150.00
Q02 2021-0.050.01120.00
Q01 2021-0.06-
Earnings Per EndEstimateRevision %Trend
7/2022 QR0.03-86.36Negative
10/2022 QR0.02-96.92Negative
4/2023 FY0.06--
4/2024 FY0.30--
Next Report Date14th Sep 2022
Estimated EPS Next Report0.03
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume491.56K
Shares Outstanding61.83K
Shares Float53.11M
Trades Count6.36K
Dollar Volume9.53M
Avg. Volume609.80K
Avg. Weekly Volume552.50K
Avg. Monthly Volume619.86K
Avg. Quarterly Volume657.03K

Avid Bioservices Inc. (NASDAQ: CDMO) stock closed at 19.36 per share at the end of the most recent trading day (a 0.94% change compared to the prior day closing price) with a volume of 491.56K shares and market capitalization of 1.20B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 227 people. Avid Bioservices Inc. CEO is Nicholas S. Green.

The one-year performance of Avid Bioservices Inc. stock is -25.97%, while year-to-date (YTD) performance is -33.65%. CDMO stock has a five-year performance of 396.41%. Its 52-week range is between 11.3 and 34.51, which gives CDMO stock a 52-week price range ratio of 34.73%

Avid Bioservices Inc. currently has a PE ratio of 9.80, a price-to-book (PB) ratio of 6.41, a price-to-sale (PS) ratio of 8.95, a price to cashflow ratio of 134.80, a PEG ratio of 2.32, a ROA of 38.53%, a ROC of 6.78% and a ROE of 105.20%. The company’s profit margin is 13.66%, its EBITDA margin is 18.40%, and its revenue ttm is $119.60 Million , which makes it $1.93 revenue per share.

Of the last four earnings reports from Avid Bioservices Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.03 for the next earnings report. Avid Bioservices Inc.’s next earnings report date is 14th Sep 2022.

The consensus rating of Wall Street analysts for Avid Bioservices Inc. is Moderate Buy (2), with a target price of $28.33, which is +46.33% compared to the current price. The earnings rating for Avid Bioservices Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avid Bioservices Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avid Bioservices Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.77, ATR14 : 1.47, CCI20 : 55.92, Chaikin Money Flow : 0.06, MACD : 0.83, Money Flow Index : 51.77, ROC : 1.89, RSI : 31.85, STOCH (14,3) : 71.02, STOCH RSI : 1.00, UO : 48.42, Williams %R : -28.98), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avid Bioservices Inc. in the last 12-months were: Catherine J. Mackey (Option Excercise at a value of $0), Daniel Ryan Hart (Option Excercise at a value of $2 830), Daniel Ryan Hart (Sold 11 337 shares of value $213 464 ), Esther Alegria (Option Excercise at a value of $0), Gregory P. Sargen (Option Excercise at a value of $0), Joseph Carleone (Option Excercise at a value of $0), Mark R. Ziebell (Option Excercise at a value of $348 075), Mark R. Ziebell (Sold 47 858 shares of value $1 242 435 ), Nicholas S. Green (Option Excercise at a value of $0), Nicholas S. Green (Sold 34 603 shares of value $636 824 ), Richard B. Hancock (Option Excercise at a value of $138 591), Richard B. Hancock (Sold 40 000 shares of value $840 076 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
2 (66.67 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
1.67

Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on development and current Good Manufacturing Practices (cGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

CEO: Nicholas S. Green

Telephone: +1 714 508-6100

Address: 2642 Michelle Drive, Tustin 92780, CA, US

Number of employees: 227

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

59%41%

Bearish Bullish

53%47%


News

Stocktwits